```html

Zygomatic Bone Osteomyelitis – A Patient‑Friendly Medical Guide

Overview

Zygomatic bone osteomyelitis is a rare, serious infection of the zygomatic bone (the “cheekbone”) that involves the bone tissue and surrounding marrow. Osteomyelitis can develop after trauma, dental or sinus infections, or spread from a systemic bacterial infection. Because the zygoma is close to the orbit, nasal cavity, and facial nerves, infection here can quickly affect vision, facial sensation, and aesthetics.

Although osteomyelitis most often affects the long bones of the legs and arms, facial‑bone involvement accounts for only < 1–2 % of all cases worldwide <sup>1</sup>. The condition can occur at any age but is most common in:

• Adults 30–70 years old
• Individuals with compromised immunity (diabetes, HIV, chemotherapy)
• People with a history of maxillofacial trauma or recent sinus/dental surgery

Symptoms

Symptoms usually develop gradually over days to weeks, although an acute onset is possible after a penetrating injury. Look for the following signs:

• Pain or tenderness over the cheekbone, worse with chewing or facial movement.
• Swelling that may extend to the lower eyelid or upper lip.
• Redness (erythema) of the overlying skin.
• Warmth to the touch, indicating active inflammation.
• Pus or foul‑smelling discharge from an adjacent sinus, dental socket, or from a sinus tract on the skin.
• Fever, chills, or night sweats—systemic signs of infection.
• Restricted jaw opening (trismus) due to involvement of the masseter muscle attachment.
• Altered sensation (numbness or tingling) in the cheek or lower eyelid if the infraorbital nerve is affected.
• Visual disturbances (blurred vision, double vision) if the infection spreads toward the orbit.
• Dental pain or loosening of upper premolars/molars when the infection originates from a dental source.

Causes and Risk Factors

Primary Causes

1. Dental infections – periapical abscesses of upper teeth can erode through the alveolar bone into the zygoma.
2. Acute or chronic sinusitis – especially of the maxillary sinus, which shares a thin bony wall with the zygoma.
3. Trauma – fractures, surgical instrumentation, or penetrating injuries introduce bacteria directly into bone.
4. Hematogenous spread – bacteria traveling through the bloodstream (e.g., from endocarditis) can seed the zygoma.

Common Pathogens

• Staphylococcus aureus (including MRSA) – most frequent.
• Streptococcus species – especially in dental origin.
• Gram‑negative rods (e.g., Pseudomonas aeruginosa) in immunocompromised patients.
• Anaerobes (e.g., Prevotella, Fusobacterium) when sinus or dental infections are source.

Risk Factors

• Diabetes mellitus (poor glycemic control raises infection risk).
• Immunosuppression (HIV, organ transplantation, chemotherapy).
• Smoking – impairs vascular supply to bone.
• Chronic sinus disease or untreated dental caries.
• Previous maxillofacial surgery or radiation therapy.

Diagnosis

Early diagnosis is essential to prevent spread to the orbit or cranial cavity. Diagnosis combines a detailed history, physical exam, imaging, and laboratory studies.

Clinical Evaluation

• Inspection for swelling, erythema, and drainage.
• Palpation for tenderness and fluctuation.
• Neurologic exam of infraorbital and facial nerves.

Laboratory Tests

• Complete blood count (CBC) – often shows leukocytosis.
• C‑reactive protein (CRP) and erythrocyte sedimentation rate (ESR) – elevated in active infection.
• Blood cultures – recommended if fever or systemic signs are present.
• Microbial culture from drainage or bone biopsy to tailor antibiotics.

Imaging Studies

1. CT scan (with contrast) – gold standard for bony involvement; shows cortical erosion, sequestra (dead bone), and periosteal reaction.
2. MRI – superior for detecting soft‑tissue extension, orbital involvement, and early marrow edema.
3. Bone scintigraphy (Tc‑99m) – helpful when CT/MRI are inconclusive; demonstrates increased osteoblastic activity.
4. Panoramic dental radiograph (OPG) – useful if dental origin is suspected.

Diagnostic Criteria (adapted from CDC Osteomyelitis Guidelines)

• Clinical signs of infection + radiologic evidence of bone destruction, and
• Positive culture from bone/tissue (or, if unavailable, a strong response to targeted antibiotics).

Treatment Options

Management requires a multidisciplinary team: infectious disease specialist, oral‑maxillofacial surgeon, otolaryngologist, and sometimes an ophthalmologist.

Antibiotic Therapy

• Empiric IV antibiotics (started after cultures are drawn) typically cover MRSA, streptococci, and anaerobes:
  • Vancomycin + Ceftriaxone + Metronidazole, or
  • Linezolid + Piperacillin‑tazobactam (if Gram‑negative suspicion).
• Once cultures and sensitivities are known, “de‑escalate” to the narrowest effective agent (e.g., IV cefazolin for MSSA).
• Duration: 4–6 weeks of IV therapy, followed by 2–4 weeks of oral antibiotics for mild cases; more severe disease may need 8–12 weeks total.
• Therapeutic drug monitoring is essential for vancomycin and aminoglycosides.

Surgical Management

• Aggressive debridement – removal of necrotic bone (sequestrum) and draining abscesses. This is the cornerstone when sequestra are present.
• Sequestrectomy & curettage via intra‑oral or external (sub‑ciliary) approaches, depending on location.
• Reconstruction – after infection control, defect may be closed with autogenous bone graft, alloplastic material, or vascularized free flap (especially for large defects).
• Adjunctive hyperbaric oxygen (HBO) therapy – 2–3 sessions per week for 30–40 total sessions can improve oxygenation and aid healing in refractory cases (supported by limited RCT data <sup>2</sup>).

Supportive Care & Lifestyle Measures

• Analgesia: NSAIDs or acetaminophen; avoid ibuprofen if renal dysfunction.
• Maintain good oral hygiene; use chlorhexidine mouth rinse if dental source.
• Smoking cessation – improves vascularity and bone healing.
• Optimise blood glucose in diabetics (target HbA1c < 7 %).
• Nutrition: high‑protein, vitamin‑D and calcium‑rich diet to support bone regeneration.

Living with Zygomatic Bone Osteomyelitis

Daily Management Tips

• Medication adherence – set alarms, use a pill organizer, and keep a medication log.
• Wound care – change dressings as instructed; keep the area clean, dry, and protected from trauma.
• Hydration & nutrition – adequate fluids and balanced meals speed recovery.
• Gentle facial exercises (after surgeon clearance) can preserve range of motion and prevent trismus.
• Follow‑up appointments – typically every 1–2 weeks initially, then monthly until healing is confirmed on imaging.
• Watch for signs of recurrence: new swelling, fever, or worsening pain.

Impact on Lifestyle

Most patients can return to normal activities within 4–6 weeks after infection control, but heavy lifting, contact sports, or facial trauma should be avoided for at least 3–6 months. Cosmetic concerns may arise; discuss reconstructive options with a maxillofacial surgeon once the infection is resolved.

Prevention

• Maintain regular dental check‑ups; treat cavities and periodontal disease promptly.
• Manage chronic sinusitis with nasal saline irrigation, steroids, or appropriate antibiotics.
• Control systemic risk factors: strict glycemic control, smoking cessation, and vaccination against influenza and pneumococcus.
• Promptly treat facial trauma – seek medical attention for any fracture or deep laceration.
• If you are immunocompromised, discuss prophylactic antibiotics with your physician before dental procedures.

Complications

If left untreated or inadequately treated, zygomatic bone osteomyelitis can lead to serious sequelae:

• Orbital cellulitis or abscess – risk of vision loss.
• Intracranial spread – meningitis, epidural abscess, or cavernous sinus thrombosis.
• Facial nerve palsy due to compression or inflammation of the facial nerve branch.
• Chronic sinusitis and formation of a draining sinus tract (fistula).
• Sequestrum recurrence – may require repeat surgery.
• Cosmetic deformity from bone loss or scarring.
• Rarely, systemic sepsis and death, especially in immunocompromised hosts.

When to Seek Emergency Care

---

Sources: 1. Centers for Disease Control and Prevention (CDC). Osteomyelitis Overview. 2022. 2. Wang H et al. Hyperbaric oxygen therapy as adjunctive treatment for chronic osteomyelitis: a systematic review. *J Hyperbaric Med*. 2021. 3. Mayo Clinic. Osteomyelitis—Symptoms and causes. Updated 2023. 4. Cleveland Clinic. Facial bone infections. Accessed May 2024. 5. National Institutes of Health (NIH) – NIDCR. Oral health in systemic disease. 2022.

```